Physician

Mark Albert Bigda, DO

According to 2025 Medicare claims, Mark Bigda, DO (NPI: 1043292089) practices internal medicine in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is MANHAN INTERNAL MEDICINE PC (NPI: 1043590417; TIN: 900745151) and primary practice location at 01027-1057.

Bigda's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 494 traditional Medicare patients, billed 2,029 HCPCS/CPT codes, and received $124,400 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 7,893 prescription claims across 557 beneficiaries totaling $806,623 in drug costs, led by Eliquis (Apixaban). DME data shows 173 claims. Open Payments data shows 27 records totaling $622. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $167,096 and ending at $124,400. Concurrently, Part D prescription costs have risen steadily, from $387,466 to $806,623. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $14,430 to $13,712.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	487	2,638	$167,096
2016	509	2,607	$159,483
2017	518	2,259	$151,601
2018	358	1,447	$90,463
2019	371	1,383	$91,858
2020	519	1,751	$123,376
2021	395	1,227	$91,650
2022	389	1,142	$80,312
2023	473	1,536	$111,752
2024	494	2,029	$124,400

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	414	7,961	$387,466
2016	494	9,049	$423,278
2017	545	9,518	$488,489
2018	525	8,977	$537,476
2019	561	8,021	$531,065
2020	564	8,219	$623,243
2021	553	7,974	$722,041
2022	538	7,479	$785,071
2023	541	8,000	$945,894
2024	557	7,893	$806,623

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	40	295	$7,304
2016	71	268	$6,800
2017	62	262	$7,524
2018	49	241	$5,331
2019	32	205	$4,223
2020	32	146	$3,511
2021	28	155	$10,871
2022	19	107	$9,664
2023	16	110	$7,106
2024	15	173	$5,328

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	73	82	$133
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	163	163	$117
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	397	917	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	88	123	$53
96127	Assessment of emotional or behavioral problems	265	328	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	130	6,045	$113,009
Trulicity	Dulaglutide	98	3,255	$105,303
Ozempic	Semaglutide	63	2,808	$86,323
Jardiance	Empagliflozin	94	4,006	$75,361
Xarelto	Rivaroxaban	38	1,620	$32,938

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	21	$1,546
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	11	$1,169
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	15	48	$632
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	21	$573
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	N/R	11	$570

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$622	Lundbeck LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Albert Bigda, DO?

Tedicare shows public-source Medicare data for Mark Albert Bigda, DO (NPI 1043292089), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Albert Bigda, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Albert Bigda, DO?

Mark Albert Bigda, DO is linked to MANHAN INTERNAL MEDICINE PC (billing NPI 1043590417) in the available physician profile data.

Does Mark Albert Bigda, DO have Open Payments data?

Mark Albert Bigda, DO has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.